Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Cryofibrinogenemia: What Rheumatologists Should Know

Author(s): Mittermayer B. Santiago* and Bartira Souza Melo

Volume 18, Issue 3, 2022

Published on: 12 May, 2022

Page: [186 - 194] Pages: 9

DOI: 10.2174/1573397118666220325110737

Price: $65

Abstract

Cryofibrinogenemia refers to the presence of cryofibrinogen in plasma. This protein has the property of precipitating at lower temperatures. Cryofibrinogenemia is a rare disorder, clinically characterized by skin lesions, such as ulcers, necrosis, livedo reticularis, arthralgia, thrombosis, and limb ischemia. These features are most often observed in rheumatological practice and consist of differential diagnoses of antiphospholipid syndrome, primary vasculitis, thrombotic thrombocytopenic purpura, and cryoglobulinemia. Classical histopathological findings include the presence of thrombi within the lumen of blood vessels of the skin without vasculitis. To date, there are no validated classification criteria. Management includes corticosteroids, immunosuppressive therapy, anticoagulants, and fibrinolytic agents. This narrative review aims to make physicians, particularly rheumatologists, aware of the existence of this underdiagnosed condition. There are no epidemiological studies evaluating the prevalence of cryofibrinogenemia in different rheumatological disorders. Studies are also required to investigate if certain features of rheumatological diseases are related to the presence of cryofibrinogenemia.

Keywords: Cryofibrinogenemia, cryofibrinogen, fibrinogen, cryoprotein, cryoglobulinemia, skin necrosis.

« Previous Next »
[1]
Amdo TD, Welker JA. An approach to the diagnosis and treatment of cryofibrinogenemia. Am J Med 2004; 116(5): 332-7.
[http://dx.doi.org/10.1016/j.amjmed.2003.09.033] [PMID: 14984819]
[2]
Blain H, Cacoub P, Musset L, et al. Cryofibrinogenaemia: A study of 49 patients. Clin Exp Immunol 2000; 120(2): 253-60.
[http://dx.doi.org/10.1046/j.1365-2249.2000.01210.x] [PMID: 10792373]
[3]
Loidi Pascual L, Larumbe Irurzun A, Álvarez Gigli ML. Cryofibrinogenemia. An uncommon cause of cold induced cutaneous lesions. Med Clin (Barc) 2016; 147(8): 372-3.
[http://dx.doi.org/10.1016/j.medcli.2016.04.010] [PMID: 27207238]
[4]
Paliwal VK, Chhirolya R, Neyaz Z, Agarwal V. Clinical reasoning: A 30-year-old man with acute paraplegia and left foot gangrene. Neurology 2018; 90(15): e1355-9.
[http://dx.doi.org/10.1212/WNL.0000000000005300] [PMID: 29632119]
[5]
Viot C, Bouldouyre MA, Chauvineau A, Boussadia A, Bakir R. Cryofibrinogenemia revealed by digital ischemia with stroke. Presse Med 2013; 42(5): 913-5.
[http://dx.doi.org/10.1016/j.lpm.2012.07.015] [PMID: 23021661]
[6]
Daumas A, Boucraut J, Bernard F, et al. Unusual cause of peripheral arterial thromboses. Rev Med Interne 2012; 33(2): 107-8.
[http://dx.doi.org/10.1016/j.revmed.2011.01.012] [PMID: 22222161]
[7]
Sakieda K, Sumikawa Y, Imaoka K, et al. Successful treatment of leg ulcer caused by cryofibrinogenemia by using a systemic corticosteroid and warfarin. Int J Dermatol 2011; 50(12): 1538-41.
[http://dx.doi.org/10.1111/j.1365-4632.2011.04928.x] [PMID: 22098003]
[8]
Moscaliuc ML, Moynahan KF. An unusual cause of leg ulcerations. Am J Med 2011; 124(4): e3-4.
[http://dx.doi.org/10.1016/j.amjmed.2010.09.026] [PMID: 21435410]
[9]
Belizna C, Loufrani L, Subra JF, et al. A 5-year prospective follow-up study in essential cryofibrinogenemia patients. Autoimmun Rev 2011; 10(9): 559-62.
[http://dx.doi.org/10.1016/j.autrev.2011.04.009] [PMID: 21549859]
[10]
Mirouse A, Malphettes M, Battistella M, Valade S. Extensive cutaneous necrosis associated with cryofibrinogenemia. Intensive Care Med 2020; 46(8): 1618-9.
[http://dx.doi.org/10.1007/s00134-020-05988-6] [PMID: 32232503]
[11]
Masri R, Damade R, Al Gain M, Bouaziz JD, Wyndham-Thomas C. Cutaneous lesions in a 69-year-old woman. Rev Med Interne 2017; 38(10): 704-7.
[http://dx.doi.org/10.1016/j.revmed.2017.06.018] [PMID: 28734580]
[12]
AlGain M, Damade R, Aucouturier F, et al. Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamide. J Eur Acad Dermatol Venereol 2017; 31(1): e38-9.
[http://dx.doi.org/10.1111/jdv.13628] [PMID: 27297832]
[13]
Iwasaki T, Nozaki H, Saito T, et al. Extensive auricular necroses as an initial symptom of cryofibrinogenemia occurring secondary to gastric diffuse large B-cell lymphoma. J Dermatol 2017; 44(10): e258-9.
[http://dx.doi.org/10.1111/1346-8138.13924] [PMID: 28664978]
[14]
Lee J, Apisarnthanarax N, Jordon RE, Duvic M. Cryofibrinogenemia in a patient with B-cell lymphoma. Clin Lymphoma 2000; 1(3): 234-7.
[http://dx.doi.org/10.3816/CLM.2000.n.020] [PMID: 11707837]
[15]
Shimoni A, Körbling M, Champlin R, Molldrem J. Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant 2000; 26(12): 1343-5.
[http://dx.doi.org/10.1038/sj.bmt.1702678] [PMID: 11223976]
[16]
Velasco-Rodríguez D, Hernández-Rivas JA, Chavarría E, Navío T, Villarrubia J. Cryofibrinogenaemia in a patient with multiple myeloma and necrotizing vasculitis. Br J Haematol 2015; 171(2): 153.
[http://dx.doi.org/10.1111/bjh.13569] [PMID: 26147252]
[17]
Elgoweini M, May C, Devgun MS, Howatson SR, Gupta G. Secondary cryofibrinogenaemia due to bronchial adenocarcinoma presenting as cutaneous necrosis. Clin Exp Dermatol 2007; 32(3): 343-4.
[http://dx.doi.org/10.1111/j.1365-2230.2006.02328.x] [PMID: 17397363]
[18]
Lazar AP, Lazar P. Giardiasis, cryofibrinogenemia, and cold sensitivity: A response to metronidazole. Int J Dermatol 1991; 30(8): 598.
[http://dx.doi.org/10.1111/j.1365-4362.1991.tb02651.x] [PMID: 1938062]
[19]
Brüning H, Christophers E. Cryofibrinogenemia-successful therapy by decreasing fibrinogen. Hautarzt 1991; 42(4): 227-32.
[PMID: 1860798]
[20]
Delluc A, Saadoun D, Ghillani-Dalbin P, Sene D, Piette JC, Cacoub P. Cryofibrinogen in patients with hepatitis C virus infection. Am J Med 2008; 121(7): 624-31.
[http://dx.doi.org/10.1016/j.amjmed.2008.03.011] [PMID: 18589059]
[21]
Begin P, Leclerc G. Images in clinical medicine. Familial primary cryofibrinogenemia. N Engl J Med 2013; 369(8): e10.
[http://dx.doi.org/10.1056/NEJMicm1300987] [PMID: 23964955]
[22]
van Geest AJ, van Dooren-Greebe RJ, Andriessen MP, Blomjous CE, Go IH. Familial primary cryofibrinogenemia. J Eur Acad Dermatol Venereol 1999; 12(1): 47-50.
[http://dx.doi.org/10.1016/S0926-9959(98)00111-1] [PMID: 10188150]
[23]
Wulffraat N, Meyer KJ, Zegers BJ, Kuis W. Familial presence of primary cryofibrinogenaemia, a report of three cases. Br J Rheumatol 1996; 35(1): 102-4.
[http://dx.doi.org/10.1093/rheumatology/35.1.102] [PMID: 8624616]
[24]
Korst DR, Kratochvil CH. Cryofibrinogen in a case of lung neoplasm associated with thrombophlebitis migrans. Blood 1955; 10(9): 945-53.
[http://dx.doi.org/10.1182/blood.V10.9.945.945] [PMID: 13250040]
[25]
Zlotnick A, Shahin W, Rachmilewitz EA. Studies in cryofibrinogenemia. Acta Haematol 1969; 42(1): 8-17.
[http://dx.doi.org/10.1159/000208756] [PMID: 4243229]
[26]
Smith SB, Arkin C. Cryofibrinogenemia: Incidence, clinical correlations, and a review of the literature. Am J Clin Pathol 1972; 58(5): 524-30.
[http://dx.doi.org/10.1093/ajcp/58.5.524] [PMID: 4642158]
[27]
McKee PAKJ, Bird RM. Incidence and significance of cryofibrinogenemia. J Lab Clin Med 1963; 61: 203-10.
[28]
Saadoun D, Elalamy I, Ghillani-Dalbin P, Sene D, Delluc A, Cacoub P. Cryofibrinogenemia: New insights into clinical and pathogenic features. Am J Med 2009; 122(12): 1128-35.
[http://dx.doi.org/10.1016/j.amjmed.2009.03.040] [PMID: 19958891]
[29]
Soyfoo MS, Goubella A, Cogan E, Wautrecht JC, Ocmant A, Stordeur P. Clinical significance of Cryofibrinogenemia: Possible pathophysiological link with Raynaud’s phenomenon. J Rheumatol 2012; 39(1): 119-24.
[http://dx.doi.org/10.3899/jrheum.110793] [PMID: 22089468]
[30]
Pindyck J, Lichtman HC, Kohl SG. Cryofibrinogenaemia in women using oral contraceptives. Lancet 1970; 1(7637): 51-3.
[http://dx.doi.org/10.1016/S0140-6736(70)91842-8] [PMID: 4188621]
[31]
Chandra RK, Malkani PK, Bhasin K. Serum levels of 2 -macroglobulin and IgG and cryofibrinogenemia in pregnancy. Obstet Gynecol 1973; 41(1): 56-9.
[PMID: 4118750]
[32]
Glueck HI, Herrmann LG. Cold-precipitable fibrinogen, Cryofibrinogen. Arch Intern Med 1964; 113(5): 748-57.
[http://dx.doi.org/10.1001/archinte.1964.00280110128024] [PMID: 14120604]
[33]
Terrier B, Izzedine H, Musset L, et al. Prevalence and clinical significance of cryofibrinogenaemia in patients with renal disorders. Nephrol Dial Transplant 2011; 26(11): 3577-81.
[http://dx.doi.org/10.1093/ndt/gfr079] [PMID: 21382997]
[34]
Sawada K, Takahashi R, Saniabadi AR, Ohdo M, Shimoyama T. Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous. World J Gastroenterol 2006; 12(10): 1621-5.
[http://dx.doi.org/10.3748/wjg.v12.i10.1621] [PMID: 16570358]
[35]
Nagy J, Ambrus M, Paal M, Trinn C, Burger T. Cryoglobulinaemia and cryofibrinogenaemia in IgA nephropathy: A follow-up study. Nephron J 1987; 46(4): 337-42.
[http://dx.doi.org/10.1159/000184385] [PMID: 3116441]
[36]
Bognár P, Görög A, Kárpáti S. High prevalence of cryofibrinogenaemia in dermatitis herpetiformis. J Eur Acad Dermatol Venereol 2016; 30(3): 517-8.
[http://dx.doi.org/10.1111/jdv.12913] [PMID: 25490996]
[37]
Ginter K, Ahsan DM, Bizjak M, et al. Cryoglobulins, cryofibrinogens, and cold agglutinins in cold urticaria: Literature review, retrospective patient analysis, and observational study in 49 patients. Front Immunol 2021; 12: 675451.
[http://dx.doi.org/10.3389/fimmu.2021.675451] [PMID: 34113348]
[38]
Gómez-Fernández C, López-Sundh AE, González-Vela C, et al. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak. Int J Dermatol 2020; 59(12): 1475-84.
[http://dx.doi.org/10.1111/ijd.15234] [PMID: 33070314]
[39]
Stathakis NE, Karamanolis D, Koukoulis G, Tsianos E. Characterization of cryofibrinogen isolated from patients plasma. Haemostasis 1981; 10(4): 195-202.
[PMID: 7250786]
[40]
Euler HH, Zeuner RA, Béress R, Gutschmidt HJ, Christophers E, Schroeder JO. Monoclonal cryo-antifibrinogenemia. Arthritis Rheum 1996; 39(6): 1066-9.
[http://dx.doi.org/10.1002/art.1780390628] [PMID: 8651973]
[41]
Nash JW, Ross P Jr, Neil Crowson A, et al. The histopathologic spectrum of cryofibrinogenemia in four anatomic sites. Skin, lung, muscle, and kidney. Am J Clin Pathol 2003; 119(1): 114-22.
[http://dx.doi.org/10.1309/KB5ARGWVL1R2BPBN] [PMID: 12520706]
[42]
Dagenais GR, Barbeau A, Delmore P. Cryofibrinogenemia and cerebrovascular accident. Can Med Assoc J 1968; 98(10): 475-8.
[PMID: 5645181]
[43]
Ibuki E, Shiraishi A, Sofue T, et al. Characteristic electron-microscopic features of cryofibrinogen-associated glomerulonephritis: A case report. BMC Nephrol 2020; 21(1): 27.
[http://dx.doi.org/10.1186/s12882-020-1696-0] [PMID: 31996260]
[44]
Sethi S, Yachoui R, Murray DL, Radhakrishnan J, Alexander MP. Cryofibrinogen-associated glomerulonephritis. Am J Kidney Dis 2017; 69(2): 302-8.
[http://dx.doi.org/10.1053/j.ajkd.2016.08.031] [PMID: 27866967]
[45]
Moiseev S, Luqmani R, Novikov P, Shevtsova T. Cryofibrinogenaemia-a neglected disease. Rheumatology (Oxford) 2017; 56(9): 1445-51.
[PMID: 27789759]
[46]
Belizna CC, Tron F, Joly P, Godin M, Hamidou M, Lévesque H. Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology (Oxford) 2008; 47(2): 205-7.
[http://dx.doi.org/10.1093/rheumatology/kem341] [PMID: 18208822]
[47]
Kalbfleisch JM, Bird RM. Cryofibrinogenemia. N Engl J Med 1960; 263(18): 881-6.
[http://dx.doi.org/10.1056/NEJM196011032631803] [PMID: 13750865]
[48]
Grada A, Falanga V. Cryofibrinogenemia-induced cutaneous ulcers: A review and diagnostic criteria. Am J Clin Dermatol 2017; 18(1): 97-104.
[http://dx.doi.org/10.1007/s40257-016-0228-y] [PMID: 27734332]
[49]
Barrett MC, Prendiville JS, Pardy BJ, Cream JJ. Cryofibrinogenaemia and acute gangrene in systemic sclerosis. Postgrad Med J 1986; 62(732): 935-6.
[http://dx.doi.org/10.1136/pgmj.62.732.935] [PMID: 3774725]
[50]
Yoshida K, Yokoyama T, Toyokawa Y, et al. Cryofibrinogenemia associated with Sjögren’s syndrome: A case of successful treatment with high-dose corticosteroid. Intern Med 2007; 46(13): 1039-42.
[http://dx.doi.org/10.2169/internalmedicine.46.6311] [PMID: 17603248]
[51]
Sandouk Z, Alirhayim Z, Hassan S, Qureshi W. Cryofibrinogenaemia: Not just skin deep. BMJ Case Rep 2013; 2013
[http://dx.doi.org/10.1136/bcr-2012-008102]
[52]
Soyfoo MS, Couturier B, Cogan E. Cryofibrinogenaemia with vasculitis: A new overlap syndrome causing severe leg ulcers and digital necrosis in rheumatoid arthritis? Rheumatology (Oxford) 2010; 49(12): 2455-7.
[http://dx.doi.org/10.1093/rheumatology/keq211] [PMID: 20659917]
[53]
Shimbo J, Miwa A, Aoki K. Cryofibrinogenemia associated with polyarteritis nodosa. Clin Rheumatol 2006; 25(4): 562-3.
[http://dx.doi.org/10.1007/s10067-005-0107-z] [PMID: 16292471]
[54]
Meehan SE, Coghill SB, Cuschieri A. A case of childhood polyarteritis nodosa associated with cryofibrinogenaemia presenting in adult-hood with massive gastrointestinal bleeding. Scott Med J 1983; 28(3): 302-5.
[http://dx.doi.org/10.1177/003693308302800319] [PMID: 6137058]
[55]
Bonaci-Nikolic B, Stefanovic L, Nikolic M. Digital necrosis due to cryofibrinogen in granulomatosis with polyangiitis--a new association. Eur J Dermatol 2013; 23(6): 914-6.
[http://dx.doi.org/10.1684/ejd.2013.2195] [PMID: 24184567]
[56]
Jantunen E, Soppi E, Neittaanmäki H, Lahtinen R. Essential cryofibrinogenaemia, leukocytoclastic vasculitis and chronic purpura. J Intern Med 1993; 234(3): 331-3.
[http://dx.doi.org/10.1111/j.1365-2796.1993.tb00752.x] [PMID: 8354986]
[57]
Griswold WR, Simon G, McIntosh RM. Anaphylactoid purpura, cold exposure, and cryofibrinogenemia. Ann Intern Med 1973; 78(4): 611.
[http://dx.doi.org/10.7326/0003-4819-78-4-611_1] [PMID: 4694049]
[58]
Cwazka WF, Sprenger JD, Naguwa SN, Birnberg FA. Cryofibrinogenemia in Henoch-Schönlein purpura: Report of a case. Arch Intern Med 1979; 139(5): 592-3.
[http://dx.doi.org/10.1001/archinte.1979.03630420078026] [PMID: 443956]
[59]
Alexopoulos E, Kirmizis D, Visvardis G, et al. Cryofibrinogenemia due to Henoch-Schönlein purpura in a patient on peritoneal dialysis. Perit Dial Int 2003; 23(1): 85-7.
[http://dx.doi.org/10.1177/089686080302300114] [PMID: 12691514]
[60]
Gerke P, Krüger S, Steinhoff J. Henoch-Schönlein purpura, cryofibrinogenaemia, and peripheral gangrene. Nephrol Dial Transplant 1999; 14(7): 1746-9.
[http://dx.doi.org/10.1093/ndt/14.7.1746] [PMID: 10435887]
[61]
Browning CE, Callen JP. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol 2006; 142(1): 75-8.
[http://dx.doi.org/10.1001/archderm.142.1.75] [PMID: 16415390]
[62]
Brown PJ, Zirwas MJ, English JC III. The purple digit: An algorithmic approach to diagnosis. Am J Clin Dermatol 2010; 11(2): 103-16.
[http://dx.doi.org/10.2165/11530180-000000000-00000] [PMID: 20141231]
[63]
Santiago MB, Paz A. Acute peripheral and/or cutaneous ischemic syndrome: What rheumatologists should know. J Clin Rheumatol 2021; 27(2): 73-9.
[http://dx.doi.org/10.1097/RHU.0000000000001609] [PMID: 33315786]
[64]
Young GD, Cleland LG, McNeil JD. Cryofibrinogenaemia: A case report. Aust N Z J Med 1991; 21(4): 444-6.
[http://dx.doi.org/10.1111/j.1445-5994.1991.tb01350.x] [PMID: 1953535]
[65]
Beebe RT, Tartaglia AP, Steiner A. Cryofibrinogenemia: A case report. Trans Am Clin Climatol Assoc 1964; 75: 138-43.
[PMID: 21408641]
[66]
Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA, Falanga V. Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia. J Am Acad Dermatol 1993; 28(1): 71-4.
[http://dx.doi.org/10.1016/0190-9622(93)70012-I] [PMID: 8425973]
[67]
Falanga V, Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet 1991; 338(8763): 347-8.
[http://dx.doi.org/10.1016/0140-6736(91)90483-6] [PMID: 1677702]
[68]
Arellano-Rodrigo E, Pons V, Nicolau I. Cryofibrinogenaemia. Br J Haematol 2008; 140(1): 2.
[PMID: 17916105]
[69]
Rubegni P, Flori ML, Fimiani M, Andreassi L. A case of cryofibrinogenaemia responsive to stanozolol. Br J Haematol 1996; 93(1): 217-9.
[http://dx.doi.org/10.1046/j.1365-2141.1996.4791016.x] [PMID: 8611463]
[70]
Criado PR, de Souza EspinelI DP, Valentef NS, Alavi A, Kirsner RS. Livedoid vasculopathy and high levels of lipoprotein (a): Response to danazol. Dermatol Ther 2015; 28(4): 248-53.
[http://dx.doi.org/10.1111/dth.12225] [PMID: 25824252]
[71]
Chartier M, Falanga V. Healing of ulcers due to cryofibrinogenemia with colchicine and high-dose pentoxifylline. Am J Clin Dermatol 2009; 10(1): 39-42.
[http://dx.doi.org/10.2165/0128071-200910010-00007] [PMID: 19170411]
[72]
Kocoloski A, Aggarwal R, Lienesch D. Successful management of secondary cryofibrinogenaemia using bosentan therapy. Rheumatology (Oxford) 2018; 57(10): 1868-70.
[http://dx.doi.org/10.1093/rheumatology/key134] [PMID: 29846727]

Rights & Permissions Print Cite
Article Metrics
23
1
© 2024 Bentham Science Publishers | Privacy Policy